scholarly journals Reversible Monoamine Oxidase-A Inhibitor (Moclobemide) and Selective Serotonin Reuptake Inhibitors (SSRI)

1994 ◽  
Vol 11 (4) ◽  
pp. 263-263
Author(s):  
Gregorio H Sorín-Lidia ◽  
S Salto-Marcela ◽  
Ucha-Ronaldo ◽  
Ucha Udabe
Keyword(s):  
Monoamine Oxidase ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Serotonin Reuptake Inhibitors ◽  
Monoamine Oxidase A ◽  
Selective Serotonin

Switching Antidepressants vs. Conventional Augmentation Strategies

CNS Spectrums ◽  
2009 ◽  
Vol 14 (S4) ◽  
pp. 11-14 ◽  
Author(s):  
George I. Papakostas
Keyword(s):  
Monoamine Oxidase ◽  
Mechanism Of Action ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Tricyclic Antidepressants ◽  
Serotonin Reuptake Inhibitors ◽  
Selective Serotonin ◽  
Augmentation Strategies ◽  
The 1960S ◽  
Norepinephrine Reuptake

Antidepressants have been available since the 1950s, when the monoamine oxidase inhibitors were first discovered. Since then, our armamentarium of antidepressants has progressively expanded with the discovery of the tricyclic antidepressants (TCAs) in the 1960s, the selective serotonin reuptake inhibitors (SSRIs) in the 1980s, and, subsequently, the serotonin norepinephrine reuptake inhibitors (SNRIs), and other agents possessing a diverse mechanism of action including buproprion, and mirtazapine.

Panic in Australia

1998 ◽  
Vol 13 (S2) ◽  
pp. 71s-74s
Author(s):  
GD Burrows ◽  
TR Norman ◽  
SR Ellen ◽  
KP Maguire ◽  
FK Judd
Keyword(s):  
Major Depression ◽  
Panic Disorder ◽  
Monoamine Oxidase ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Tricyclic Antidepressants ◽  
Serotonin Reuptake Inhibitors ◽  
Selective Serotonin ◽  
Psychiatric Conditions ◽  
To Receive

SummaryPanic disorder is widespread in Australia, often in combination with other psychiatric conditions such as agoraphobia or major depression. Pharmacotherapy for panic disorder in Australia commenced with benzodiazepines, and later progressed to tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs). More recently, treatment has moved towards use of the selective serotonin reuptake inhibitors (SSRIs), which are effective and better tolerated. Paroxetine is the first drug of this class to receive approval for treatment of panic disorder in Australia.

Sign in / Sign up

Export Citation Format

Share Document